Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REVVITY, INC. | Director | Common Stock | 11.3K | $1.17M | $103.49 | May 1, 2024 | Direct |
Regulus Therapeutics Inc. | Director | Stock Option (Right to Buy) | 60K | May 20, 2024 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | By Trust | |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Stock Option (Right to Buy) | 0 | Oct 6, 2023 | Direct |